RN7SL259P

Across TCGA pan-cancer cohorts, RN7SL259P RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of RN7SL259P’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where RN7SL259P RNA is repressed in tumor relative to normal tissue. In most cancer types RN7SL259P is over-expressed in tumor, although a few such as COAD and THCA show the opposite, repressed pattern.

COAD and THCA are the cancer types where RN7SL259P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RN7SL259P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	All	II,III,IV	−0.047	.010	3	view →
THCA	All	All	−0.051	.035	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

RN7SL259P–COAD

Open the COAD breakdown →